Track topics on Twitter Track topics that are important to you
AIDS cholangiopathy is biliary obstruction secondary to biliary tract strictures caused by various opportunistic infections. Before the advent of highly active antiretroviral therapy, cholangiopat...
Maryland, the US state on the mid-Atlantic coast, is hub of biotechnology institutions and companies. In 2005/2006 is was the 2nd best area globally for initiatives aimed at drawing and retaining bi...
India, in the Asian subcontinent is the world’s fourth largest producer of pharmaceuticals, and is thought as one of the most promising biotech markets in the world. Several important steps ...
* Says it signs framework agreement on medical project in Shangqiu city with investment about 3 billion yuan ($462.76 million)
Lawrence O. Gostin, Georgetown University There is no story in global health as transformative, awe-inspiring, and yet as tragic as the AIDS pandemic. The disease was unknown only a generation ago —...
Today is World AIDS Day and for many Americans who are HIV positive or who have AIDS, the outlook for those living with the disease has never – thankfully – been more promising. The HI...
The Ryan White HIV/AIDS Treatment Extension Act of 2009 (formerly the Comprehensive AIDS Resources Emergency Act) was first enacted into law in 1990, and amended in 1996, 2000, 2006, and 2009. In FY...
CDC's Act Against AIDS initiative suggests actions you can take to fight HIV/AIDS in the Hispanic/Latino community, for National Latino AIDS Awareness Day and the rest of the year.
Despite major advances, HIV/AIDS remains one of the world's most significant public health challenges, particularly in low and middle income countries. Reuters Health Information
Yesterday was National Youth HIV/AIDS Awareness Day, an opportunity to educate on the impact of HIV and AIDS and to recognize advances in science that have brought hope to Americans. Thank...
* Says it signs framework agreement to set up medical product production base with investment of about 300 million yuan ($46.19 million)
The Investment Framework Enhanced (IFE) proposed in 2013 by the Joint United Nations Programme on HIV/AIDS (UNAIDS) explored how maximizing existing interventions and adding emerging prevention option...
Non-AIDS defining cancers (non-ADCs) have become the leading non-AIDS-related cause of death among people with HIV/AIDS. We aimed to quantify the excess risk of cancer-related deaths among Italian peo...
In 2011 a new Investment Framework was proposed that described how the scale-up of key HIV interventions could dramatically reduce new HIV infections and AIDS-related deaths in low and middle income c...
The purpose is to review recent insights into the impact of HIV-associated immune activation on AIDS and non-AIDS morbidity and mortality.
Despite considerable advances in the prevention and treatment of HIV/AIDS, the burden of new infections of HIV and AIDS varies substantially across the country. Previous studies have demonstrated asso...